(603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 603520 · · 13 pages · Chinese
Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Starry Pharmaceutical
- (603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend Briefing
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Resolutions of the 2nd Meeting of the 6th Board of Directors
- Announcement on Results of Shareholding Reduction by the Actual Controller and Completion of Internal Share Transfer Among Persons Acting in Concert
- Announcement on Release of Pledge over Shares Held by the Controlling Shareholder
Follow Zhejiang Starry Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Starry Pharmaceutical